Massachussets General Hospital and Harvard Medical School,
Boston, MA, United States
It is with great pleasure and honor that I succeed Dr. Leo Buhler in his post of IXA President. Over the past two years, Dr. Buhler has uniquely contributed to the development of the International Xenotransplantation Association (IXA) and its Journal. On behalf of the Association, I wish to thank Dr. Buhler for his strong leadership. I look forward to continue the advancement of our society over the next two years.
Last October, the Ludwig Maximilian University in Munich hosted the 15th International Xenotransplantation Association Congress. The Congress was an outstanding success, both scientifically and socially. Thank you to Congress Chairs Eckhard Wolf and Bruno Reichart for developing a rich and forward-looking scientific program in a relaxing and historical atmosphere. The numerous scientific highlights of the meeting were summarized by Peter Cowan in the closing session and in the IXA Newsletter. This year’s meeting illustrated that the pace of progress in our field has accelerated over the last few years and that the timeline for clinical application is shortening.
After the Munich meeting the IXA Council met to discuss the state and direction of the association. The discussion was largely inspired and driven by the results of the recent member survey. I am very happy to report that the IXA Council has taken resolutions to create several new initiatives:
These initiatives will rely on the dedicated and hard work of our vibrant IXA Council members. We will share further updates on the progress of these and other activities with you throughout the year.
Importantly, the realization of these goals relies in part on your contributions. I thank you for participating in our membership survey and providing useful and relevant comments and suggestions. I would like to encourage your continued contribution of ideas and suggestions to improve our society.
With my best wishes,
Dear participants of the IXA2019 Congress,
It was our great pleasure to host the main event of the International Xenotransplantation Association in Munich and we hope that you all enjoyed it as much as we did. We would like to thank all speakers and presenters from academia, industry and the regulatory authorities, who impressively documented the momentum that xenotransplantation research has taken up over the last years. It was particularly encouraging to see how many young researchers adopted xenotransplantation as their research topic, all pulling together to move xenotransplantation of cells, tissues and organs to clinical application. Thus, our Society is facing very exciting times, probably the most exciting ever.
Very best wishes and see you at the IXA/IPITA/CTRMS Congress 2021 in San Diego!